Rob Beatty, MD FACEP
Iodine allergy is a term often used by patients who experience adverse reactions to iodine-containing compounds. However, the term is a misnomer since true allergic reactions to iodine itself are rare. In medical imaging, iohexol is an iodinated contrast medium commonly used to enhance visualization during CT scans, angiography, and other diagnostic imaging procedures. The use of iohexol in patients with a history of iodine allergy or shellfish allergy has been a topic of debate among medical professionals. This article will discuss the incidence of true allergic reactions to iohexol, cross-reactivity with shellfish allergy, and current disagreement regarding the validity of iodine allergy.
Iodine the Element
Iodine is an essential element for human health and is required for the synthesis of thyroid hormones. However, adverse reactions to iodine-containing compounds are not uncommon, with symptoms ranging from mild rash to severe anaphylaxis. Despite the prevalence of these reactions, true allergy to iodine itself is rare. This is because iodine is not an antigen and cannot stimulate an immune response. Rather, it is the iodinated compounds used in medical imaging that can cause adverse reactions.
Iodinated Contrast Dyes
Iohexol is a nonionic iodinated contrast medium that is commonly used in medical imaging. It works by increasing the contrast between different tissues, allowing for better visualization of structures within the body. Iohexol is generally well-tolerated, with adverse reactions occurring in less than 1% of patients. These reactions can range from mild itching or hives to severe anaphylaxis, which can be life-threatening.
One of the most common concerns regarding the use of iohexol is cross-reactivity with shellfish allergy. Shellfish allergy is one of the most common food allergies, affecting approximately 2% of the population. The allergenic proteins in shellfish are not related to iodine, but rather to tropomyosin, a muscle protein. However, many shellfish species contain high levels of iodine, leading to confusion among patients and healthcare providers.
Despite the widespread belief that shellfish allergy increases the risk of adverse reactions to iohexol, the evidence suggests otherwise. Studies have shown that the incidence of adverse reactions to iohexol is similar in patients with and without a history of shellfish allergy. This suggests that the allergenic proteins in shellfish are not cross-reactive with iohexol and that shellfish allergy is not a risk factor for adverse reactions to iohexol.
“True Iodine Allergy” is a Misnomer
Another source of confusion regarding the use of iohexol is the notion of true iodine allergy. Tue allergy to iodine itself is rare, with only a handful of cases reported in the medical literature. However, many patients report a history of iodine allergy, often based on a previous adverse reaction to an iodine-containing compound.
This discrepancy between perceived iodine allergy and true allergy has led to disagreement among medical professionals regarding the use of iohexol in patients with a history of iodine allergy. Some argue that the term iodine allergy should be abandoned altogether, as it is misleading and contributes to unnecessary anxiety and avoidance of medical imaging procedures. Others argue that the term should be retained, as a subset of patients may have true allergy to iodinated compounds that can cause severe reactions.
The controversy surrounding the validity of iodine allergy highlights the need for better education and communication between healthcare providers and patients. Patients with a history of adverse reactions to iodine-containing compounds should be evaluated carefully to determine whether they have a true allergy or a non-allergic adverse reaction. If a true allergy is suspected, alternative imaging modalities that do not require iodinated contrast should be considered. However, if the patient has a non-allergic adverse reaction or a history of perceived iodine allergy, the use of iohexol may still be appropriate after careful evaluation of the risks and benefits.
True Incidence of Iohexol Reactions
It is important to note that the incidence of true allergic reactions to iohexol is low, with rates ranging from 0.1% to 0.01%. This is because iohexol is a nonionic contrast medium, which has a lower osmolality and a decreased tendency to release histamine, compared to older ionic contrast agents. The risk of adverse reactions can be further reduced by using a lower dose of iohexol. Premedicating with antihistamines or corticosteroids may also reduce risk. It may also make the radiology tech feel better about performing the study. Patients of concern should be closely monitored during and after the procedure.
Is Pretreatment Necessary?
Certainly, pretreatment regimens are a strategy used to prevent or reduce the severity of adverse reactions to iodinated contrast media. The most commonly used pretreatment medications are antihistamines and corticosteroids. The use of pretreatment regimens varies among medical institutions and is usually reserved for patients with a history of moderate or severe reactions to contrast media, as well as those at high risk of developing such reactions.
Antihistamines
Antihistamines are typically given orally, intravenously, or subcutaneously before the procedure. They work by blocking the action of histamine, a chemical released by the body in response to an allergen. The recommended antihistamines for pretreatment include diphenhydramine, hydroxyzine, and cetirizine. Diphenhydramine is the most commonly used antihistamine, as it has a fast onset of action and a long duration of effect. Hydroxyzine and cetirizine are also effective and have fewer sedative effects than diphenhydramine.
Corticosteroids
Corticosteroids, such as prednisone, are also used as pretreatment to prevent allergic reactions to iodinated contrast media. They work by suppressing the immune system and reducing inflammation. Corticosteroids are typically given orally or intravenously, starting a few hours before the procedure and continuing for several days afterward. The use of corticosteroids as pretreatment has been shown to be effective in reducing the incidence and severity of allergic reactions to contrast media.
Despite their widespread use, the efficacy of pretreatment regimens in preventing adverse reactions to contrast media is still a topic of debate. Some studies have shown that pretreatment with antihistamines and corticosteroids can reduce the incidence of mild and moderate reactions, but not severe reactions. Other studies have suggested that pretreatment does not significantly reduce the risk of adverse reactions and may even increase the risk of contrast-induced nephropathy (CIN), a type of kidney damage caused by contrast media.
There is also some controversy over the optimal timing and dosing of pretreatment medications. Some guidelines recommend giving antihistamines and corticosteroids the night before the procedure, while others recommend giving them just before the procedure. The dosing of corticosteroids also varies among institutions, with some recommending a high dose and others recommending a lower dose.
Recommendation Without Clear Evidence
Pretreatment regimens with antihistamines and corticosteroids are commonly used to prevent adverse reactions to iodinated contrast media. While their efficacy in preventing reactions is still debated, they are generally recommended for patients with a history of moderate or severe reactions, or those at high risk of developing such reactions. The optimal timing and dosing of pretreatment medications vary among institutions and should be based on individual patient factors. As with any medical intervention, the risks and benefits of pretreatment should be carefully considered. Patients should be informed of the potential benefits and risks of pretreatment, as well as the alternative options, such as using a different imaging modality or avoiding contrast media altogether.
Conclusion
In conclusion, iodine allergy is a misnomer, as true allergy to iodine itself is rare. Adverse reactions to iodine-containing compounds, such as iohexol, are more common but still relatively uncommon. Cross-reactivity between shellfish allergy and iohexol is unlikely, and the validity of iodine allergy is a topic of ongoing debate among medical professionals. Patients with a history of adverse reactions to iodinated contrast should be evaluated carefully to determine the nature of their reaction and the appropriateness of iohexol administration. The use of iohexol can be safe and effective when administered appropriately, with close monitoring and consideration of risk factors. Improved education and communication between healthcare providers and patients can help to alleviate anxiety and improve patient outcomes.
Sources:
- Wang CL, Cohan RH, Ellis JH, et al. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol. 2008;191(2):409-415.
- Brockow K, Christiansen C, Kanny G, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy. 2005;60(2):150-158.
- Lasser EC, Berry CC, Talner LB, et al. Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material. N Engl J Med. 1987;317(14):845-849.
- Cohen MD. Adverse reactions to iodinated contrast material. Radiol Clin North Am. 1996;34(2):495-510.
- Greenberger PA, Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol. 1991;87(5):867-872.
